The backlash against bioequivalence and the interchangeability of brand-name and generic drugs

Lignende værker

• Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics
  af: Vijay, Aishwarya, et al.
  Udgivet: (2019)
• The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
  af: Sarpatwari, Ameet, et al.
  Udgivet: (2016)
• Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review
  af: van der Meersch, Amélie, et al.
  Udgivet: (2011)
• Brand and generic medications: Are they interchangeable?
  af: Al-Jazairi, Abdulrazaq S., et al.
  Udgivet: (2008)
• Generic and Brand-Name l-Thyroxine Are Not Bioequivalent for Children With Severe Congenital Hypothyroidism
  af: Carswell, Jeremi M., et al.
  Udgivet: (2013)